Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers

Breast-conserving therapy (BCT) for sporadic breast cancer has been widely accepted by surgeons and patients alike. While BCT is associated with a higher risk of ipsilateral breast tumor recurrence (IBTR), it has not been shown to decrease overall survival (OS) in comparison with mastectomy. Many wo...

Descripción completa

Detalles Bibliográficos
Autores principales: Croshaw, Randal L., Marshall, Megan L., Williams, Tesha L., Erb, Kathleen M., Julian, Thomas B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262559/
https://www.ncbi.nlm.nih.gov/pubmed/22295226
http://dx.doi.org/10.4061/2011/481563

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262559/
https://www.ncbi.nlm.nih.gov/pubmed/22295226
http://dx.doi.org/10.4061/2011/481563

Ejemplares similares